Venous Thrombosis and Stenosis After Implantation of Pacemakers and Defibrillators

Overview

Journal J Interv Card Electrophysiol

Publisher Springer

Date 2005 Jun 25

PMID 15976973

Citations 57

Authors

Grzegorz Rozmus

James P Daubert

David T Huang

Spencer Rosero

Burr Hall

Charles Francis

Affiliations

Soon will be listed here.

Abstract

Venous complications of pacemaker/ implantable cardioverter defibrillator (ICD) system implantation rarely cause immediate clinical problems. The challenge starts when patients come for system revision or upgrade. Numerous reports of venous complications such as stenosis, occlusions, and superior vena cava syndrome have been published. We reviewed current knowledge of these complications, management, and their impact on upgrade/revision procedures. One study has suggested that intravenous lead infection promotes local vein stenosis. Another found that the presence of a temporary wire before implantation is associated with an increased risk of stenosis. Although data for ICD leads is based only on three studies-it suggests that the rate of venous complications is very similar to that of pacing systems, and probably data from pacing leads can be extrapolated to ICD leads. Despite 40 years of experience with transcutaneous implanted intravenous pacing systems and dozens of studies, we were unable to identify clear risk factors (confirmed by independent studies) that lead to venous stenosis. Neither the hardware (lead size, number and material) nor the access site choice (cephalic cut down, subclavian or axillary puncture) appears to affect rate of venous complications. A few factors were proposed as predictors of severe venous stenosis/occlusion: presence of multiple pacemaker leads (compared to a single lead), use of hormone therapy, personal history of venous thrombosis, the presence of temporary wire before implantation, previous presence of a pacemaker (ICD as an upgrade) and the use of dual-coil leads. Anticoagulant therapy (for other reasons than pacemaker lead) seemed to have protective antithrombotic effect.

Citing Articles

Interface properties of nanostructured carbon-coated biological implants: an overview.

Bartoli M, Cardano F, Piatti E, Lettieri S, Fin A, Tagliaferro A Beilstein J Nanotechnol. 2024; 15:1041-1053.

PMID: 39161465 PMC: 11331541. DOI: 10.3762/bjnano.15.85.

Multilevel Venous Obstruction in Patients with Cardiac Implantable Electronic Devices.

Czajkowski M, Polewczyk A, Jachec W, Kosior J, Nowosielecka D, Tulecki L Medicina (Kaunas). 2024; 60(2).

PMID: 38399623 PMC: 10890105. DOI: 10.3390/medicina60020336.

Prevalence and Predictors of Venous Stenosis Following First Transvenous Cardiac Implantable Electronic Device Implantation.

Yousuf Q, Rashid A, Hafeez I, Rather H, Syed I, Mir A J Saudi Heart Assoc. 2023; 35(4):301-310.

PMID: 38116403 PMC: 10727134. DOI: 10.37616/2212-5043.1358.

Recurrent Transient Ischemic Attacks in a Patient with Multiple Pacemaker Leads.

Shwe T, Javed A, Patel R, Akhrass P J Innov Card Rhythm Manag. 2023; 14(4):5424-5430.

PMID: 37143573 PMC: 10153006. DOI: 10.19102/icrm.2023.14042.

[Endoluminal balloon dilatation of impacted central venous catheter-Case report and literature review].

Setia A, Khan S, Knez P, Rouhollahpour A, Adili F Chirurgie (Heidelb). 2023; 94(8):714-718.

PMID: 37115224 DOI: 10.1007/s00104-023-01861-6.

References

Spittell P, Hayes D . Venous complications after insertion of a transvenous pacemaker. Mayo Clin Proc. 1992; 67(3):258-65. DOI: 10.1016/s0025-6196(12)60103-7. View

Sabeti S, Schillinger M, Mlekusch W, Haumer M, Ahmadi R, Minar E . Treatment of subclavian-axillary vein thrombosis: long-term outcome of anticoagulation versus systemic thrombolysis. Thromb Res. 2003; 108(5-6):279-85. DOI: 10.1016/s0049-3848(03)00093-8. View

Joffe H, Goldhaber S . Upper-extremity deep vein thrombosis. Circulation. 2002; 106(14):1874-80. DOI: 10.1161/01.cir.0000031705.57473.1c. View

Nishino M, Tanouchi J, Ito T, Tanaka K, Aoyama T, Kitamura M . Echographic detection of latent severe thrombotic stenosis of the superior vena cava and innominate vein in patients with a pacemaker: integrated diagnosis using sonography, pulse Doppler, and color flow. Pacing Clin Electrophysiol. 1997; 20(4 Pt 1):946-52. DOI: 10.1111/j.1540-8159.1997.tb05498.x. View

Kommareddy A, Zaroukian M, Hassouna H . Upper extremity deep venous thrombosis. Semin Thromb Hemost. 2002; 28(1):89-99. DOI: 10.1055/s-2002-20567. View

Tilney M, Griffiths H, Edwards E . Natural history of major venous thrombosis of the upper extremity. Arch Surg. 1970; 101(6):792-6. DOI: 10.1001/archsurg.1970.01340300148026. View

Blackburn T, Dunn M . Pacemaker-induced superior vena cava syndrome: consideration of management. Am Heart J. 1988; 116(3):893-6. DOI: 10.1016/0002-8703(88)90361-4. View

Sticherling C, Chough S, Baker R, Wasmer K, Oral H, Tada H . Prevalence of central venous occlusion in patients with chronic defibrillator leads. Am Heart J. 2001; 141(5):813-6. DOI: 10.1067/mhj.2001.114195. View

Oginosawa Y, Abe H, Nakashima Y . The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads. Pacing Clin Electrophysiol. 2002; 25(11):1605-11. DOI: 10.1046/j.1460-9592.2002.01605.x. View

10.

Bettmann M . Noninvasive and venographic diagnosis of deep vein thrombosis. Cardiovasc Intervent Radiol. 1988; 11 Suppl:S15-20. DOI: 10.1007/BF02577091. View

11.

Abe H, Takahara K, Nakashima Y, Kuroiwa A . Effect of low dose aspirin on augmented plasminogen activator inhibitor type 1 activity in patients with permanent pacemakers. Pacing Clin Electrophysiol. 1994; 17(2):146-51. DOI: 10.1111/j.1540-8159.1994.tb01365.x. View

12.

Hingorani A, Ascher E, Lorenson E, DePippo P, Salles-Cunha S, Scheinman M . Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. J Vasc Surg. 1997; 26(5):853-60. DOI: 10.1016/s0741-5214(97)70100-9. View

13.

Crook B, Gishen P, Robinson C, Oram S . Occlusion of the subclavian vein associated with cephalic vein pacemaker electrodes. Br J Surg. 1977; 64(5):329-31. DOI: 10.1002/bjs.1800640508. View

14.

Chan A, Bhatt D, Wilkoff B, Roffi M, Mukherjee D, Gray B . Percutaneous treatment for pacemaker-associated superior vena cava syndrome. Pacing Clin Electrophysiol. 2002; 25(11):1628-33. DOI: 10.1046/j.1460-9592.2002.01628.x. View

15.

Lickfett L, Bitzen A, Arepally A, Nasir K, Wolpert C, Jeong K . Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace. 2003; 6(1):25-31. DOI: 10.1016/j.eupc.2003.09.001. View

16.

Chang R, Horne 3rd M, Mayo D, Doppman J . Pulse-spray treatment of subclavian and jugular venous thrombi with recombinant tissue plasminogen activator. J Vasc Interv Radiol. 1996; 7(6):845-51. DOI: 10.1016/s1051-0443(96)70858-8. View

17.

Zuber M, Huber P, Fricker U, Buser P, Jager K . Assessment of the subclavian vein in patients with transvenous pacemaker leads. Pacing Clin Electrophysiol. 1999; 21(12):2621-30. DOI: 10.1111/j.1540-8159.1998.tb00039.x. View

18.

Francis C, Starkey I, Errington M, Gillespie I . Venous stenting as treatment for pacemaker-induced superior vena cava syndrome. Am Heart J. 1995; 129(4):836-7. DOI: 10.1016/0002-8703(95)90341-0. View

19.

Montgomery J, DSouza V, Dyer R, Formanek A, Prabhu S . Nonsurgical treatment of the superior vena cava syndrome. Am J Cardiol. 1985; 56(12):829-30. DOI: 10.1016/0002-9149(85)91162-2. View

20.

Demeter S, Pritchard J, Piedad O, Cordasco E, Taherj S . Upper extremity thrombosis: etiology and prognosis. Angiology. 1982; 33(11):743-55. DOI: 10.1177/000331978203301107. View